Join
Live feed
·
INSIDERFilingvia Quantisnow
Intra-Cellular Therapies Inc. logo

Halstead Michael sold $1,353,235 worth of shares (20,477 units at $66.09) and converted options into 7,345 shares, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ITCI· Intra-Cellular Therapies Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ITCI (Intra-Cellular Therapies Inc.) and more on Quantisnow.